Duncan McHale, M.B.B.S.
2020
In 2020, Duncan McHale, M.B.B.S. earned a total compensation of $1.2M as Chief Medical Officer at Evelo Biosciences.
Compensation breakdown
| Non-Equity Incentive Plan | $228,276 |
|---|---|
| Option Awards | $565,403 |
| Salary | $409,000 |
| Other | $24,692 |
| Total | $1,227,371 |
MBBS received $565.4K in option awards, accounting for 46% of the total pay in 2020.
MBBS also received $228.3K in non-equity incentive plan, $409K in salary and $24.7K in other compensation.
Rankings
In 2020, Duncan McHale, M.B.B.S.'s compensation ranked 7,738th out of 13,090 executives tracked by ExecPay. In other words, MBBS earned more than 40.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,738 out of 13,090 | 41st |
Division Manufacturing | 3,263 out of 5,618 | 42nd |
Major group Chemicals And Allied Products | 1,321 out of 2,251 | 41st |
Industry group Drugs | 1,144 out of 1,951 | 41st |
Industry Pharmaceutical Preparations | 852 out of 1,456 | 42nd |
Source: SEC filing on April 26, 2021.
MBBS' colleagues
We found two more compensation records of executives who worked with Duncan McHale, M.B.B.S. at Evelo Biosciences in 2020.